Generic Pharmaceuticals Key findings, summary and notes
The OECD Competition Committee held a roundtable discussion on Generic Pharmaceuticals in October 2009. This document includes an executive summary and the documents from the meeting: an analytical note by the staff of the United States Federal Trade Commission, written submissions from Canada, the...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Paris
OECD Publishing
2010
|
| Series: | OECD Roundtables on Competition Policy Papers
|
| Subjects: | |
| Online Access: | |
| Collection: | OECD Books and Papers - Collection details see MPG.ReNa |
| Summary: | The OECD Competition Committee held a roundtable discussion on Generic Pharmaceuticals in October 2009. This document includes an executive summary and the documents from the meeting: an analytical note by the staff of the United States Federal Trade Commission, written submissions from Canada, the Czech Republic, the European Commission, India, Indonesia, Ireland, Italy, Japan, Korea, Norway, the Russian Federation, South Africa, Spain, Sweden, the United Kingdom, the United States, and BIAC, as well as an aide-memoire |
|---|---|
| Physical Description: | 209 p |